The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
GM-CSF: A Double-Edged Sword in Cancer Immunotherapy
Open accessAbstract
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a cytokine that drives the generation of myeloid cell subsets including neutrophils, monocytes, macrophages, and dendritic cells in response to stress, infections, and cancers. By modulating the functions of innate immune cells that serve as a bridge to activate adaptive immune responses, GM-CSF globally impacts host immune surveillance under pathologic conditions. As with other soluble mediators of immunity, too much or too little GM-CSF has been found to promote cancer aggressiveness. While too little GM-CSF prevents the appropriate production of innate immune cells and subsequent activation of adaptive anti-cancer immune responses, too much of GM-CSF can exhaust immune cells and promote cancer growth. The consequences of GM-CSF signaling in cancer progression are a function of the levels of GM-CSF, the cancer type, and the tumor microenvironment. In this review, we first discuss the secretion of GM-CSF, signaling downstream of the GM-CSF receptor, and GM-CSF’s role in modulating myeloid cell homeostasis. We then outline GM-CSF’s anti-tumorigenic and pro-tumorigenic effects both on the malignant cells and on the non-malignant immune and other cells in the tumor microenvironment. We provide examples of current clinical and preclinical strategies that harness GM-CSF’s anti-cancer potential while minimizing its deleterious effects. We describe the challenges in achieving the Goldilocks effect during administration of GM-CSF-based therapies to patients with cancer. Finally, we provide insights into how technologies that map the immune microenvironment spatially and temporally may be leveraged to intelligently harness GM-CSF for treatment of malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, H., Jia, R., Zhao, T., Li, X., Lang, M., Lan, C., Wang, H., Li, Z., Zhou, B., Wu, L., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.036 · Cited by 23
RetractedMyeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., & Steinman, R. M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1693 · Cited by 3,738
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
Fajgenbaum, D. C., & June, C. H. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2026131 · Cited by 3,196
Lutz, M. B., Kukutsch, N., Ogilvie, A. L. J., Rößner, S., Koch, F., Romani, N., & Schuler, G. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00204-x · Cited by 2,966
An immunogenic personal neoantigen vaccine for patients with melanoma
Ott, P. A., Hu, Z., Keskin, D. B., Shukla, S. A., Sun, J., Bozym, D. J., Zhang, W., Luoma, A., Giobbie-Hurder, A., Peter, L., et al. (2017) · Nature · doi:10.1038/nature22991 · Cited by 2,936
Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V, Hamada, H., Pardoll, D., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,818
L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
Geiger, R., Rieckmann, J. C., Wolf, T., Basso, C., Feng, Y., Fuhrer, T., Kogadeeva, M., Picotti, P., Meissner, F., Mann, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.031 · Cited by 1,775
GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells
Caux, C., Dezutter-Dambuyant, C., Schmitt, D., & Banchereau, J. (1992) · Nature · doi:10.1038/360258a0 · Cited by 1,554
Regulation of Immune Responses by Prostaglandin E2
Kalinski, P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101029 · Cited by 1,474
Lin, Y., Xu, J., & Lan, H. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0760-3 · Cited by 1,398 · cited 2×
“Polarization of TAMs into the tumorpromoting M2 phenotype is controlled by factors secreted by the tumor and surrounding cells (118), such as C-Cmotif chemokine ligand 2 (CCL2) (119).”
BackgroundNeutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?
Rosales, C. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00113 · Cited by 1,334 · cited 1×
“1 GM-CSF Restores Neutrophil-Driven Immune Responses in Cancers Of the downstream immune effectors of GM-CSF, neutrophils are particularly important because they are the most abundant WBCs and therefore, one of the first immune cell types to respond to infections (64) and cancers.”
BackgroundKeren, L., Bosse, M., Marquez, D., Angoshtari, R., Jain, S., Varma, S., Yang, S.-R., Kurian, A., Van Valen, D., West, R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.039 · Cited by 1,183
Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization
Vergadi, E., Ieronymaki, E., Lyroni, K., Vaporidi, K., & Tsatsanis, C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601515 · Cited by 1,148
Teachey, D. T., Lacey, S. F., Shaw, P. A., Melenhorst, J. J., Maude, S. L., Frey, N., Pequignot, E., Gonzalez, V. E., Chen, F., Finklestein, J., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0040 · Cited by 1,102
Bayne, L. J., Beatty, G. L., Jhala, N., Clark, C. E., Rhim, A. D., Stanger, B. Z., & Vonderheide, R. H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.025 · Cited by 947 · cited 1×
“In PDAC, MDSCs that develop from tumor-derived GM-CSF also inhibit antigen-specific CD8 T cell responses (153).”
BackgroundCaux, C., Vanbervliet, B., Massacrier, C., Dezutter-Dambuyant, C., de Saint-Vis, B., Jacquet, C., Yoneda, K., Imamura, S., Schmitt, D., & Banchereau, J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.695 · Cited by 920
The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors
Metcalf, D. (1986) · Blood · doi:10.1182/blood.v67.2.257.257 · Cited by 897
Stanley, E., Lieschke, G. J., Grail, D., Metcalf, D., Hodgson, G., Gall, J. A., Maher, D. W., Cebon, J., Sinickas, V, & Dunn, A. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5592 · Cited by 882
Involvement of Granulocyte-Macrophage Colony-Stimulating Factor in Pulmonary Homeostasis
Dranoff, G., Crawford, A. D., Sadelain, M., Ream, B., Rashid, A., Bronson, R. T., Dickersin, G. R., Bachurski, C. J., Mark, E. L., Whitsett, J. A., et al. (1994) · Science · doi:10.1126/science.8171324 · Cited by 879
Ko, J. S., Zea, A. H., Rini, B. I., Ireland, J. L., Elson, P., Cohen, P., Golshayan, A., Rayman, P. A., Wood, L., Garcia, J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1332 · Cited by 862
Origin of the Lamina Propria Dendritic Cell Network
Bogunovic, M., Ginhoux, F., Helft, J., Shang, L., Hashimoto, D., Greter, M., Liu, K., Jakubzick, C., Ingersoll, M. A., Leboeuf, M., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.010 · Cited by 861
Manz, M. G., & Boettcher, S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3660 · Cited by 855
Liu, B. L., Robinson, M., Han, Z.-Q., Branston, R. H., English, C., Reay, P., McGrath, Y., Thomas, S. K., Thornton, M., Bullock, P., et al. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301885 · Cited by 803
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
Cheever, M. A., & Higano, C. S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3126 · Cited by 780
Su, S., Liu, Q., Chen, J., Chen, J., Chen, F., He, C., Huang, D., Wu, W., Lin, L., Huang, W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.021 · Cited by 772
Fatty acid transport protein 2 reprograms neutrophils in cancer
Veglia, F., Tyurin, V. A., Blasi, M., De Leo, A., Kossenkov, A. V., Donthireddy, L., To, T. K. J., Schug, Z., Basu, S., Wang, F., et al. (2019) · Nature · doi:10.1038/s41586-019-1118-2 · Cited by 751
Zigmond, E., Varol, C., Farache, J., Elmaliah, E., Satpathy, A. T., Friedlander, G., Mack, M., Shpigel, N., Boneca, I. G., Murphy, K. M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.026 · Cited by 750
Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism
Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J. H., Apolloni, E., Serafini, P., Zanovello, P., & Segal, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.689 · Cited by 690
Molecular physiology of granulocyte-macrophage colony-stimulating factor
Gasson, J. (1991) · Blood · doi:10.1182/blood.v77.6.1131.1131 · Cited by 651
Sterner, R. M., Sakemura, R., Cox, M. J., Yang, N., Khadka, R. H., Forsman, C. L., Hansen, M. J., Jin, F., Ayasoufi, K., Hefazi, M., et al. (2019) · Blood · doi:10.1182/blood-2018-10-881722 · Cited by 621
Therapeutic targeting of the angiopoietin–TIE pathway
Saharinen, P., Eklund, L., & Alitalo, K. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.278 · Cited by 620
GM-CSF Regulates Alveolar Macrophage Differentiation and Innate Immunity in the Lung through PU.1
Shibata, Y., Berclaz, P.-Y., Chroneos, Z. C., Yoshida, M., Whitsett, J. A., & Trapnell, B. C. (2001) · Immunity · doi:10.1016/s1074-7613(01)00218-7 · Cited by 618
Schneider, C., Nobs, S. P., Kurrer, M., Rehrauer, H., Thiele, C., & Kopf, M. (2014) · Nature Immunology · doi:10.1038/ni.3005 · Cited by 614
Purification and properties of colony-stimulating factor from mouse lung-conditioned medium.
Burgess, A. W., Camakaris, J., & Metcalf, D. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71855-3 · Cited by 613
Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization
Arranz, A., Doxaki, C., Vergadi, E., Martinez de la Torre, Y., Vaporidi, K., Lagoudaki, E. D., Ieronymaki, E., Androulidaki, A., Venihaki, M., Margioris, A. N., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119038109 · Cited by 608
Yu, J., Du, W., Yan, F., Wang, Y., Li, H., Cao, S., Yu, W., Shen, C., Liu, J., & Ren, X. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201449 · Cited by 606
Soiffer, R., Lynch, T., Mihm, M., Jung, K., Rhuda, C., Schmollinger, J. C., Hodi, F. S., Liebster, L., Lam, P., Mentzer, S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13141 · Cited by 571
Roca, H., Varsos, Z. S., Sud, S., Craig, M. J., Ying, C., & Pienta, K. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042671 · Cited by 569
Le, D. T., Lutz, E., Uram, J. N., Sugar, E. A., Onners, B., Solt, S., Zheng, L., Diaz, L. A., Donehower, R. C., Jaffee, E. M., et al. (2013) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31829fb7a2 · Cited by 564
Ushach, I., & Zlotnik, A. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ru0316-144r · Cited by 551 · cited 5×
“Antibody-mediated blockade of GM-CSF converts the inflammatory profile of monocytes to an immunomodulatory one by reducing human leukocyte antigen (HLA)-DR, CD86, IL-1b and tumor necrosis factor (TNF)-a and by increasing their IL-10 production (36).”
BackgroundInfluentialHolland, S. J., Pan, A., Franci, C., Hu, Y., Chang, B., Li, W., Duan, M., Torneros, A., Yu, J., Heckrodt, T. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2997 · Cited by 550
Shi, Y., Liu, C. H., Roberts, A. I., Das, J., Xu, G., Ren, G., Zhang, Y., Zhang, L., Yuan, Z. R., Tan, H. S. W., et al. (2006) · Cell Research · doi:10.1038/sj.cr.7310017 · Cited by 547
Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer
Ali, K., Soond, D. R., Piñeiro, R., Hagemann, T., Pearce, W., Lim, E. L., Bouabe, H., Scudamore, C. L., Hancox, T., Maecker, H., et al. (2014) · Nature · doi:10.1038/nature13444 · Cited by 529
Non-redundant functions of EMT transcription factors
Stemmler, M. P., Eccles, R. L., Brabletz, S., & Brabletz, T. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0196-y · Cited by 524
Gilliet, M., Boonstra, A., Paturel, C., Antonenko, S., Xu, X.-L., Trinchieri, G., O'Garra, A., & Liu, Y.-J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020045 · Cited by 524
Serafini, P., Carbley, R., Noonan, K. A., Tan, G., Bronte, V., & Borrello, I. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0757 · Cited by 523
IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice
Bronte, V., Serafini, P., De Santo, C., Marigo, I., Tosello, V., Mazzoni, A., Segal, D. M., Staib, C., Lowel, M., Sutter, G., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.270 · Cited by 513
Wang, T.-T., Zhao, Y.-L., Peng, L.-S., Chen, N., Chen, W., Lv, Y.-P., Mao, F.-Y., Zhang, J.-Y., Cheng, P., Teng, Y.-S., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313075 · Cited by 509
STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
Vasquez-Dunddel, D., Pan, F., Zeng, Q., Gorbounov, M., Albesiano, E., Fu, J., Blosser, R. L., Tam, A. J., Bruno, T., Zhang, H., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci60083 · Cited by 507
l -Arginine Consumption by Macrophages Modulates the Expression of CD3ζ Chain in T Lymphocytes
Rodriguez, P. C., Zea, A. H., DeSalvo, J., Culotta, K. S., Zabaleta, J., Quiceno, D. G., Ochoa, J. B., & Ochoa, A. C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1232 · Cited by 492
Sierra-Filardi, E., Nieto, C., Domínguez-Soto, Á., Barroso, R., Sánchez-Mateos, P., Puig-Kroger, A., López-Bravo, M., Joven, J., Ardavín, C., Rodríguez-Fernández, J. L., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302821 · Cited by 482
Bingisser, R. M., Tilbrook, P. A., Holt, P. G., & Kees, U. R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.5729 · Cited by 480
GM-CSF, IL-3, and IL-5 Family of Cytokines: Regulators of Inflammation
Dougan, M., Dranoff, G., & Dougan, S. K. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.022 · Cited by 458
Lang, R. A., Metcalf, D., Cuthbertson, R. A., Lyons, I., Stanley, E., Kelso, A., Kannourakis, G., Williamson, D. J., Klintworth, G. K., Gonda, T. J., et al. (1987) · Cell · doi:10.1016/0092-8674(87)90136-x · Cited by 366
G-CSF and GM-CSF in Neutropenia
Mehta, H. M., Malandra, M., & Corey, S. J. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500861 · Cited by 363
van de Laar, L., Coffer, P. J., & Woltman, A. M. (2012) · Blood · doi:10.1182/blood-2011-11-370130 · Cited by 358
Sakamaki, K., Miyajima, I., Kitamura, T., & Miyajima, A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05437.x · Cited by 341
Kim, J. (1997) · Immunology Letters · doi:10.1016/s0165-2478(97)86917-9 · Cited by 339
Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment
Mussai, F., De Santo, C., Abu-Dayyeh, I., Booth, S., Quek, L., McEwen-Smith, R. M., Qureshi, A., Dazzi, F., Vyas, P., & Cerundolo, V. (2013) · Blood · doi:10.1182/blood-2013-01-480129 · Cited by 332
Characterization of resident and migratory dendritic cells in human lymph nodes
Segura, E., Valladeau-Guilemond, J., Donnadieu, M.-H., Sastre-Garau, X., Soumelis, V., & Amigorena, S. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111457 · Cited by 326
Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis
Waight, J. D., Netherby, C., Hensen, M. L., Miller, A., Hu, Q., Liu, S., Bogner, P. N., Farren, M. R., Lee, K. P., Liu, K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68189 · Cited by 323
Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma
Ferrucci, P. F., Pala, L., Conforti, F., & Cocorocchio, E. (2021) · Cancers · doi:10.3390/cancers13061383 · Cited by 317
Czystowska-Kuzmicz, M., Sosnowska, A., Nowis, D., Ramji, K., Szajnik, M., Chlebowska-Tuz, J., Wolinska, E., Gaj, P., Grazul, M., Pilch, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10979-3 · Cited by 312
The Structure of the GM-CSF Receptor Complex Reveals a Distinct Mode of Cytokine Receptor Activation
Hansen, G., Hercus, T. R., McClure, B. J., Stomski, F. C., Dottore, M., Powell, J., Ramshaw, H., Woodcock, J. M., Xu, Y., Guthridge, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.05.053 · Cited by 311
Hercus, T. R., Thomas, D., Guthridge, M. A., Ekert, P. G., King-Scott, J., Parker, M. W., & Lopez, A. F. (2009) · Blood · doi:10.1182/blood-2008-12-164004 · Cited by 307
Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients
Parmiani, G., Castelli, C., Pilla, L., Santinami, M., Colombo, M. P., & Rivoltini, L. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl158 · Cited by 300
Kim, J. J., Ayyavoo, V, Bagarazzi, M. L., Chattergoon, M. A., Dang, K., Wang, B., Boyer, J. D., & Weiner, D. B. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.2.816 · Cited by 295
Hemopoietic responses in mice injected with purified recombinant murine GM-CSF.
Metcalf, D., Begley, C. G., Dj, W., Ec, N., De Lamarter, J., Mermod, J., Thatcher, D. R., & Schmidt, A. S. (1987) · PubMed · Cited by 269
Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy
Bhattacharya, P., Budnick, I., Singh, M., Thiruppathi, M., Alharshawi, K., Elshabrawy, H., Holterman, M. J., & Prabhakar, B. S. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0149 · Cited by 264
Shaul, M. E., Levy, L., Sun, J., Mishalian, I., Singhal, S., Kapoor, V., Horng, W., Fridlender, G., Albelda, S. M., & Fridlender, Z. G. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1232221 · Cited by 259
Fong, L., Kwek, S. S., O'Brien, S., Kavanagh, B., McNeel, D. G., Weinberg, V., Lin, A. M., Rosenberg, J., Ryan, C. J., Rini, B. I., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3529 · Cited by 246
Vremec, D., Lieschke, G. J., Dunn, A. R., Robb, L., Metcalf, D., & Shortman, K. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270107 · Cited by 245
Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types
Hong, I.-S. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.64 · Cited by 240
The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis
Kingston, D., Schmid, M. A., Onai, N., Obata-Onai, A., Baumjohann, D., & Manz, M. G. (2009) · Blood · doi:10.1182/blood-2009-02-206318 · Cited by 236
Van Overmeire, E., Stijlemans, B., Heymann, F., Keirsse, J., Morias, Y., Elkrim, Y., Brys, L., Abels, C., Lahmar, Q., Ergen, C., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-0869 · Cited by 227
Roles of GM-CSF in the Pathogenesis of Autoimmune Diseases: An Update
Lotfi, N., Thome, R., Rezaei, N., Zhang, G.-X., Rezaei, A., Rostami, A., & Esmaeil, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01265 · Cited by 227
GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches
Lang, F. M., Lee, K. M.-C., Teijaro, J. R., Becher, B., & Hamilton, J. A. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0357-7 · Cited by 221
Fong, L., Carroll, P., Weinberg, V., Chan, S., Lewis, J., Corman, J., Amling, C. L., Stephenson, R. A., Simko, J., Sheikh, N. A., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju268 · Cited by 215
Morales, J. K., Kmieciak, M., Knutson, K. L., Bear, H. D., & Manjili, M. H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0622-8 · Cited by 214
Mittendorf, E. A., Lu, B., Melisko, M., Price Hiller, J., Bondarenko, I., Brunt, A. M., Sergii, G., Petrakova, K., & Peoples, G. E. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2867 · Cited by 212
Higano, C. S., Corman, J. M., Smith, D. C., Centeno, A. S., Steidle, C. P., Gittleman, M., Simons, J. W., Sacks, N., Aimi, J., & Small, E. J. (2008) · Cancer · doi:10.1002/cncr.23669 · Cited by 210
GM-CSF: An immune modulatory cytokine that can suppress autoimmunity
Bhattacharya, P., Thiruppathi, M., Elshabrawy, H. A., Alharshawi, K., Kumar, P., & Prabhakar, B. S. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.030 · Cited by 210
Emerging role of PTEN loss in evasion of the immune response to tumours
Vidotto, T., Melo, C. M., Castelli, E., Koti, M., dos Reis, R. B., & Squire, J. A. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0834-6 · Cited by 209
Pivotal Roles of GM‐CSF in Autoimmunity and Inflammation
Shiomi, A., & Usui, T. (2015) · Mediators of Inflammation · doi:10.1155/2015/568543 · Cited by 201
The Ontogeny of Monocyte Subsets
Wolf, A. A., Yáñez, A., Barman, P. K., & Goodridge, H. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01642 · Cited by 201
GM-CSF Mediates Mesenchymal–Epithelial Cross-talk in Pancreatic Cancer
Waghray, M., Yalamanchili, M., Dziubinski, M., Zeinali, M., Erkkinen, M., Yang, H., Schradle, K. A., Urs, S., Pasca Di Magliano, M., Welling, T. H., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0947 · Cited by 197
Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells
Lichtenstein, D. A., Schischlik, F., Shao, L., Steinberg, S. M., Yates, B., Wang, H.-W., Wang, Y., Inglefield, J., Dulau-Florea, A., Ceppi, F., et al. (2021) · Blood · doi:10.1182/blood.2021011898 · Cited by 196
Kohanbash, G., McKaveney, K., Sakaki, M., Ueda, R., Mintz, A. H., Amankulor, N., Fujita, M., Ohlfest, J. R., & Okada, H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4124 · Cited by 191
Li, B., VanRoey, M., Wang, C., Chen, T.-H. T., Korman, A., & Jooss, K. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1825 · Cited by 191
The roles of CSF s on the functional polarization of tumor‐associated macrophages
Jeannin, P., Paolini, L., Adam, C., & Delneste, Y. (2018) · The FEBS Journal · doi:10.1111/febs.14343 · Cited by 184
Wedén, S., Klemp, M., Gladhaug, I. P., Møller, M., Eriksen, J. A., Gaudernack, G., & Buanes, T. (2011) · International Journal of Cancer · doi:10.1002/ijc.25449 · Cited by 183
Gonzalez-Juarrero, M., Hattle, J. M., Izzo, A., Junqueira-Kipnis, A. P., Shim, T. S., Trapnell, B. C., Cooper, A. M., & Orme, I. M. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1204723 · Cited by 183
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma
Jacquelot, N., Seillet, C., Wang, M., Pizzolla, A., Liao, Y., Hediyeh-zadeh, S., Grisaru-Tal, S., Louis, C., Huang, Q., Schreuder, J., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00943-z · Cited by 180
Ikeda, S., Okamoto, T., Okano, S., Umemoto, Y., Tagawa, T., Morodomi, Y., Kohno, M., Shimamatsu, S., Kitahara, H., Suzuki, Y., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.09.010 · Cited by 178
Cytokine Patterns in Brain Tumour Progression
Albulescu, R., Codrici, E., Popescu, I. D., Mihai, S., Necula, L. G., Petrescu, D., Teodoru, M., & Tanase, C. P. (2013) · Mediators of Inflammation · doi:10.1155/2013/979748 · Cited by 171
Zhan, Y., Lieschke, G. J., Grail, D., Dunn, A. R., & Cheers, C. (1998) · Blood · doi:10.1182/blood.v91.3.863 · Cited by 170
Eubank, T. D., Roberts, R. D., Khan, M., Curry, J. M., Nuovo, G. J., Kuppusamy, P., & Marsh, C. B. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1405 · Cited by 166
Metcalf, D. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5327 · Cited by 160
Ino, Y., Yamazaki–Itoh, R., Oguro, S., Shimada, K., Kosuge, T., Závada, J., Kanai, Y., & Hiraoka, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055146 · Cited by 160
Sachdeva, M., Duchateau, P., Depil, S., Poirot, L., & Valton, J. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ac119.007558 · Cited by 159
Potent CD4+ T Cell Responses Elicited by a Bicistronic HIV-1 DNA Vaccine Expressing gp120 and GM-CSF
Barouch, D. H., Santra, S., Tenner-Racz, K., Racz, P., Kuroda, M. J., Schmitz, J. E., Jackson, S. S., Lifton, M. A., Freed, D. C., Perry, H. C., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.562 · Cited by 158
Spath, S., Komuczki, J., Hermann, M., Pelczar, P., Mair, F., Schreiner, B., & Becher, B. (2017) · Immunity · doi:10.1016/j.immuni.2017.01.007 · Cited by 158
Lehtonen, A., Matikainen, S., Miettinen, M., & Julkunen, I. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.3.511 · Cited by 157
Lai, I. K., Swaminathan, S., Baylot, V., Mosley, A. R., Dhanasekaran, R., Gabay, M., & Felsher, D. W. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0431-x · Cited by 156
Self-citationMonocyte lineage–derived IL-6 does not affect chimeric antigen receptor T-cell function
Singh, N., Hofmann, T. J., Gershenson, Z., Levine, B. L., Grupp, S. A., Teachey, D. T., & Barrett, D. M. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2017.04.001 · Cited by 151
Lin, Y., Yang, X., Liu, W., Li, B., Yin, W., Shi, Y., & He, R. (2017) · Oncogene · doi:10.1038/onc.2016.516 · Cited by 143
Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck
Ninck, S., Reisser, C., Dyckhoff, G., Helmke, B. M., Bauer, H., & Herold‐Mende, C. C. (2003) · International Journal of Cancer · doi:10.1002/ijc.11188 · Cited by 141
ZEB 1‐regulated inflammatory phenotype in breast cancer cells
Katsura, A., Tamura, Y., Hokari, S., Harada, M., Morikawa, M., Sakurai, T., Takahashi, K., Mizutani, A., Nishida, J., Yokoyama, Y., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12098 · Cited by 124
Bai, Y., Bai, L., Zhou, J., Chen, H., & Zhang, L. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.10.008 · Cited by 124
Bron, L. P., Jandus, C., Andrejevic‐Blant, S., Speiser, D. E., Monnier, P., Romero, P. J., & Rivals, J. (2012) · International Journal of Cancer · doi:10.1002/ijc.27728 · Cited by 119
Alternative activation of macrophages by IL‐4 requires SHIP degradation
Weisser, S. B., McLarren, K. W., Voglmaier, N., van Netten‐Thomas, C. J., Antov, A., Flavell, R. A., & Sly, L. M. (2011) · European Journal of Immunology · doi:10.1002/eji.201041105 · Cited by 118
Phillips, D. J., Schürch, C. M., Khodadoust, M. S., Kim, Y. H., Nolan, G. P., & Jiang, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.687673 · Cited by 118
Iwasaki-Arai, J., Iwasaki, H., Miyamoto, T., Watanabe, S., & Akashi, K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021843 · Cited by 114
Su, X., Xu, Y., Fox, G. C., Xiang, J., Kwakwa, K. A., Davis, J. L., Belle, J. I., Lee, W., Wong, W., Fontana, F., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145296 · Cited by 114
Thorn, M., Guha, P., Cunetta, M., Espat, N. J., Miller, G., Junghans, R. P., & Katz, S. C. (2016) · Cancer Gene Therapy · doi:10.1038/cgt.2016.19 · Cited by 113
Zhao, J., Chen, L., Shu, B., Tang, J., Zhang, L., Xie, J., Qi, S., & Xu, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092691 · Cited by 110
Novel GM-CSF signals via IFN-γR/IRF-1 and AKT/mTOR license monocytes for suppressor function
Ribechini, E., Hutchinson, J. A., Hergovits, S., Heuer, M., Lucas, J., Schleicher, U., Garrote, A.-L. J., Potter, S. J., Riquelme, P., Brackmann, H., et al. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017006858 · Cited by 107
Zhan, Y., Lew, A. M., & Chopin, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02679 · Cited by 104
Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch
Guthridge, M. A., Powell, J. A., Barry, E. F., Stomski, F. C., McClure, B. J., Ramshaw, H. S., Felquer, F. A., Dottore, M., Thomas, D., To, B., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600948 · Cited by 102
Urdinguio, R. G., Fernández, A. F., Moncada-Pazos, Á., Huidobro, C., Rodríguez, R. M. A., Ferrero, C., Martínez‐Camblor, P., Obaya, Á. J., Bernal, T., Parra‐Blanco, A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0806 · Cited by 99
Eubank, T. D., Roberts, R. D., Galloway, M., Wang, Y., Cohn, D. E., & Marsh, C. B. (2004) · Immunity · doi:10.1016/j.immuni.2004.10.011 · Cited by 98
Opposing roles for HIF-1α and HIF-2α in the regulation of angiogenesis by mononuclear phagocytes
Eubank, T. D., Roda, J. M., Liu, H., O'Neil, T., & Marsh, C. B. (2010) · Blood · doi:10.1182/blood-2010-01-261792 · Cited by 98
CCL18 in the Progression of Cancer
Korbecki, J., Olbromski, M., & Dzięgiel, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217955 · Cited by 97
Chen, G., Gupta, R., Petrik, S., Laiko, M., Leatherman, J. M., Asquith, J. M., Daphtary, M. M., Garrett-Mayer, E. S., Davidson, N. E., Hirt, K., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0058 · Cited by 96
Huang, D., Song, S., Wu, Z.-Z., Wu, W., Cui, X., Chen, J.-N., Zeng, M., & Su, S.-C. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2706 · Cited by 96
Arnold, I. C., Borán, M. S., Gurtner, A., Bertram, K., Bauer, M., Frangež, Ž., Becher, B., Köpf, M., Yousefi, S., Simon, H., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190706 · Cited by 96
GM‐CSF promotes migration of human monocytes across the blood brain barrier
Vogel, D. Y. S., Kooij, G., Heijnen, P. D. A. M., Breur, M., Peferoen, L. A. N., van der Valk, P., de Vries, H. E., Amor, S., & Dijkstra, C. D. (2015) · European Journal of Immunology · doi:10.1002/eji.201444960 · Cited by 94
Cianfarani, F., Tommasi, R., Failla, C. M., Viviano, M. T., Annessi, G., Papi, M., Zambruno, G., & Odorisio, T. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06925.x · Cited by 92
Lemieux, B., Tartas, S., Traullé, C., Espinouse, D., Thiéblemont, C., Bouafia, F., Alhusein, Q., Antal, D., Salles, G., & Coiffier, B. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704467 · Cited by 91
Reggiani, F., Labanca, V., Mancuso, P., Rabascio, C., Talarico, G., Orecchioni, S., Manconi, A., & Bertolini, F. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0914 · Cited by 91
T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice
Wada, H., Noguchi, Y., Marino, M. W., Dunn, A. R., & Old, L. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12557 · Cited by 87
Ruffolo, L. I., Jackson, K. M., Kuhlers, P. C., Dale, B. S., Figueroa-Guilliani, N., Ullman, N. A., Burchard, P. R., Qin, S., Juviler, P. G., Keilson, J. M., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-324109 · Cited by 85
Hicks, K. C., Chariou, P. L., Ozawa, Y., Minnar, C. M., Knudson, K. M., Meyer, T. J., Bian, J., Cam, M., Schlom, J., & Gameiro, S. R. (2021) · Nature Communications · doi:10.1038/s41467-021-25393-x · Cited by 83
Grote, K., Schuett, H., Salguero, G., Grothusen, C., Jagielska, J., Drexler, H., Mühlradt, P. F., & Schieffer, B. (2010) · Blood · doi:10.1182/blood-2009-05-224402 · Cited by 81
Lazarus, H. M., Ragsdale, C. E., Gale, R. P., & Lyman, G. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.706186 · Cited by 80
The CIS Family: Negative Regulators of JAK–STAT Signaling
Yoshimura, A. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)00019-7 · Cited by 79
Chen, Z., Zhang, S., Han, N., Jiang, J., Xu, Y., Ma, D., Lu, L., Guo, X., Qiu, M. R., Huang, Q., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.691605 · Cited by 79
Egea, L., McAllister, C. S., Lakhdari, O., Minev, I., Shenouda, S., & Kagnoff, M. F. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202368 · Cited by 78
GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer
Nebiker, C. A., Han, J., Eppenberger‐Castori, S., Iezzi, G., Hirt, C., Amicarella, F., Cremonesi, E., Huber, X., Padovan, E., Angrisani, B., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2774 · Cited by 78
Roda, J. M., Sumner, L. A., Evans, R., Phillips, G. S., Marsh, C. B., & Eubank, T. D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100841 · Cited by 74
King, R. J., Shukla, S. K., He, C., Vernucci, E., Thakur, R., Attri, K. S., Dasgupta, A., Chaika, N. V., Mulder, S. E., Abrego, J., et al. (2022) · Oncogene · doi:10.1038/s41388-021-02132-6 · Cited by 74
GM-CSF Monocyte-Derived Cells and Langerhans Cells As Part of the Dendritic Cell Family
Lutz, M. B., Strobl, H., Schuler, G., & Romani, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01388 · Cited by 73
Wang, Y., Han, G., Wang, K., Liu, G., Wang, R., He, X., Li, X., Hou, C., Shen, B., Guo, R., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1459 · Cited by 71
Suarez‐Carmona, M., Bourcy, M., Lesage, J., Leroi, N., Syne, L., Blacher, S., Hubert, P., Erpicum, C., Foidart, J., Delvenne, P., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4546 · Cited by 70
Kyriakopoulos, C. E., Eickhoff, J. C., Ferrari, A. C., Schweizer, M. T., Wargowski, E., Olson, B. M., & McNeel, D. G. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0945 · Cited by 68
Qiu, C., Xie, Q., Zhang, D., Chen, Q., Hu, J., & Xu, L. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358652 · Cited by 66
Effective DNA Vaccination Against Listeriosis by Prime/Boost Inoculation with the Gene Gun
Fensterle, J., Grode, L., Hess, J., & Kaufmann, S. H. E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4510 · Cited by 65
Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer
Ma, Z., Lian, J., Yang, M., Wuyang, J., Zhao, C., Chen, W., Liu, C., Zhao, Q., Lou, C., Han, J., et al. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.03.012 · Cited by 65
Molecular Engineering of Therapeutic Cytokines
Vazquez-Lombardi, R., Roome, B., & Christ, D. (2013) · Antibodies · doi:10.3390/antib2030426 · Cited by 62
A core of kinase-regulated interactomes defines the neoplastic MDSC lineage
Gato, M., de Morentin, X. M., Blanco‐Luquin, I., Fernández‐Irigoyen, J., Zudaire, I., Liechtenstein, T., Arasanz, H., Lozano, T., Casares, N., Chaikuad, A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4746 · Cited by 61
Evaluation of the effect of GM-CSF blocking on the phenotype and function of human monocytes
Lotfi, N., Zhang, G., Esmaeil, N., & Rostami, A. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-58131-2 · Cited by 61
Xue, L., Yi, Y., Xu, Q., Wang, L., Yang, X., Zhang, Y., Hua, X., Chai, X., Yang, J., Chen, Y., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00299-6 · Cited by 61
Isolation and Characterization of Neutrophils with Anti-Tumor Properties
Sionov, R. V., Assi, S., Gershkovitz, M., Sagiv, J. Y., Polyansky, L., Mishalian, I., Fridlender, Z. G., & Granot, Z. (2015) · Journal of Visualized Experiments · doi:10.3791/52933 · Cited by 60
Management of neutropenia in cancer patients.
Lustberg, M. B. (2012) · PubMed · Cited by 59
Ghirelli, C., Zollinger, R., & Soumelis, V. (2010) · Blood · doi:10.1182/blood-2010-01-266932 · Cited by 55
Tian, H., Shi, G., Wang, Q., Li, Y., Yang, Q., Li, C., Yang, G., Wu, M., Xie, Q., Zhang, S., et al. (2016) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2016.25 · Cited by 54
In vitro effects of GM-CSF on mature peripheral blood neutrophils.
Fossati, G., Mazzucchelli, I., Gritti, D., Ricevuti, G., Edwards, S. W., MOULDING, D. A., & Rossi, M. L. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm.1.6.943 · Cited by 52
Schneider, U. C., Schilling, L., Schroeck, H., Nebe, C. T., Vajkoczy, P., & Woitzik, J. (2007) · Stroke · doi:10.1161/01.str.0000259707.43496.71 · Cited by 51
Molecular structure of the IL‐3, GM‐CSF and IL‐5 receptors
Miyajima, A. (1992) · The International Journal Of Cell Cloning · doi:10.1002/stem.5530100302 · Cited by 51
Nasi, M. L., Lieberman, P., BUSAM, K. J., Prieto, V., Panageas, K. S., Lewis, J. J., Houghton, A. N., & Chapman, P. B. (1999) · PubMed · Cited by 51
Rong, Q., Wang, F., Guo, Z., Hu, Y., An, S., Luo, M., Zhang, H., Wu, S., Huang, H., & Fu, L. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01374-y · Cited by 51
Brunsvig, P. F., Guren, T. K., Nyakas, M., Steinfeldt-Reisse, C., Rasch, W., Kyte, J. A., Juul, H. V., Aamdal, S., Gaudernack, G., & Inderberg, E. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.572172 · Cited by 46
Tobacco Carcinogen–Induced Production of GM-CSF Activates CREB to Promote Pancreatic Cancer
Srinivasan, S., Totiger, T. M., Shi, C., Castellanos, J. A., Lamichhane, P., Dosch, A. R., Messaggio, F., Kashikar, N., Honnenahally, K. M., Ban, Y. J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0579 · Cited by 44
Chang, C. Y., Tai, J. A., Li, S., Nishikawa, T., & Kaneda, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.9743 · Cited by 40
Kumar, A., Rani, L., Mhaske, S. T., Pote, S. T., Behera, S., Mishra, G. C., & Wani, M. R. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1801629 · Cited by 40
Self-citationChen, Y., Zhao, Z. J., Chen, Y., Lv, Z., Ding, X., Wang, R., He, X., Hou, C., Shen, B., Feng, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08047-1 · Cited by 36
Mashima, H., Zhang, R., Kobayashi, T., Hagiya, Y., Tsukamoto, H., Liu, T., Iwama, T., Yamamoto, M., Lin, C., Nakatsuka, R., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1814620 · Cited by 34
Perez, F. A., Fligner, C. L., & Yu, E. Y. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.4931 · Cited by 33
Clinical use of hematopoietic growth factors in allogeneic bone marrow transplantation
Lazarus, H. M. (1994) · Blood Reviews · doi:10.1016/0268-960x(94)90078-v · Cited by 30
Kashima, Y., Togashi, Y., Fukuoka, S., Kamada, T., Irie, T., Suzuki, A., Nakamura, Y., Shitara, K., Minamide, T., Yoshida, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-79385-w · Cited by 30
Stathopoulos, G. (2011) · Oncology Reports · doi:10.3892/or.2011.1226 · Cited by 29
Ji, Q., Gondek, D. C., & Hurwitz, A. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1456 · Cited by 28
Transgenic Expression of GM-CSF in T Cells Causes Disseminated Histiocytosis
van Nieuwenhuijze, A. E. M., Coghill, E., Gray, D. H. D., Prato, S., Metcalf, D., Alexander, W. S., & Wicks, I. P. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.09.014 · Cited by 28
Ishii, K., Shalabi, H., Yates, B., Delbrook, C., Mackall, C. L., Fry, T. J., & Shah, N. N. (2016) · Blood · doi:10.1182/blood.v128.22.3358.3358 · Cited by 28
Zheng, Q., Li, X., Cheng, X., Cui, T., Zhuo, Y., Ma, W., Zhao, X., Zhao, P., Liu, X., & Feng, W. (2017) · Tumor Biology · doi:10.1177/1010428317692232 · Cited by 22
Serum granulocyte macrophage-colony stimulating factor: a tumor marker in colorectal carcinoma?
Demırcı, U., Çoşkun, U., Sancak, B., et al. (2009) · PubMed · Cited by 21
Huang, H., Chen, C.-Y., Huang, Y., Yeh, C., Wang, C., Chang, C., & Lin, K. (2021) · Oncogene · doi:10.1038/s41388-021-02087-8 · Cited by 20
Mordoh, A., Aris, M., Carri, I., Bravo, A., Podaza, E., Pardo, J. C. T., Cueto, G. R., Barrio, M. M., & Mordoh, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.842555 · Cited by 20
Pampena, M. B., Cartar, H. C., Cueto, G. R., Levy, E. M., Blanco, P. A., Barrio, M. M., & Mordoh, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02531 · Cited by 16
Obiorah, I. E., Chahine, J. J., Ko, K., Park, B. U., deGuzman, J., & Kallakury, B. (2019) · Gastroenterology Research · doi:10.14740/gr1156 · Cited by 15
Martinez, M. E., Ono, N., Planutiene, M., Planutis, K., Nelson, E. L., & Holcombe, R. F. (2012) · Cancer Cell International · doi:10.1186/1475-2867-12-2 · Cited by 15
GM-CSF up-regulates the expression of CCL2 by T lymphocytes in mammary tumor-bearing mice
Owen, J. L., Torroella‐Kouri, M., Handel-Fernandez, M. E., & Iragavarapu‐Charyulu, V. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.20.1.129 · Cited by 14
Martinez, M., Ono, N., Planutiene, M., Planutis, K., Nelson, E. L., & Holcombe, R. F. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-80 · Cited by 11
CIS calibrates GM-CSF signalling strength to regulate macrophage polarization via a STAT5-IRF8 axisPreprint
Zhang, S., Rautela, J., Bediaga, N. G., Kolesnik, T. B., You, Y., Dagley, L. F., Bedő, J., Wang, H., Sun, L. J., Sutherland, R. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.31.486495 · Cited by 1
Cited by
M1/M2 macrophages and their overlaps – myth or reality?
Strizova, Z., Benesova, I., Bartolini, R., Novysedlak, R., Cecrdlova, E., Foley, L. K., & Striz, I. (2023) · Clinical Science · doi:10.1042/cs20220531 · Cited by 612
Targeting cytokine and chemokine signaling pathways for cancer therapy
Yi, M., Li, T., Niu, M., Zhang, H., Wu, Y., Wu, K., & Dai, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01868-3 · Cited by 455
New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay
Wan, Z., Floryan, M. A., Coughlin, M. F., Zhang, S., Zhong, A. X., Shelton, S. E., Wang, X., Xu, C., Barbie, D. A., & Kamm, R. D. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202201784 · Cited by 84
Neutrophils and Neutrophil-Based Drug Delivery Systems in Anti-Cancer Therapy
Wahnou, H., El Kebbaj, R., Hba, S., Ouadghiri, Z., El Faqer, O., Pinon, A., Liagre, B., Limami, Y., & Duval, R. E. (2025) · Cancers · doi:10.3390/cancers17071232 · Cited by 35
Metadata
- Authors
- Kumar, A., Taghi Khani, A., Sanchez Ortiz, A., & Swaminathan, S.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2022-07-05
- Volume
- 13
- Pages
- 901277-901277
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W4283808194
- Cited by
- 265
- References
- 187
- FWCI
- 16.13
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.